ArticleRheumatology international2025
The incidence of hypersensitivity to non-steroid anti-inflammatory drugs in the group of patients with rheumatoid musculoskeletal disorders: the cross-sectional study.
Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Coumarins in musculoskeletal health: a systematic review.Frontiers in nutrition · 2026Pooled it
- Anti-Inflammatory Properties of Resveratrol.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in patients with musculoskeletal disorders. However, hypersensitivity reactions to NSAIDs represent a significant clinical issue.This study aimed to assess the incidence of NSAID hypersensitivity in patients with musculoskeletal disorders and to identify associated risk factors.A total of 343 patients (aged 18-88) with chronic or recurrent musculoskeletal pain were enrolled. Participants completed a questionnaire regarding sociodemographic data, comorbidities, NSAID intake, and side effects. Patients with clinical features of NSAID hypersensitivity were identified and analysis of hypersensitivity risk factors was performed.The study included 343 patients suffering from rheumatic diseases, the most common of which were rheumatoid arthritis (45%), osteoarthritis (32%) and seronegative spondyloarthropathies (11%). However, 24.78% met the criteria for NSAID hypersensitivity. The most common reactions were NSAID-induced urticaria/angioedema (25.88%), delayed hypersensitivity, and NSAID-exacerbated respiratory disease (NERD). The symptoms were most frequently associated with ketoprofen (29%) and diclofenac (25%). Key risk factors for hypersensitivity included daily NSAID intake, asthma, chronic urticaria, smoking, aspirin use at cardiological doses, and a history of allergic reactions. Patients with hypersensitivity had significantly more chronic diseases compared to non-hypersensitive individuals (2.73 ± 2.29 vs. 1.68 ± 1.92; p = 0.0437). A logistic regression model demonstrated a sensitivity of 84.7% and specificity of 72.1% for identifying high-risk patients in teaching and respectively 80.0% and 71.7% in validation group.Identifying high-risk individuals can optimize pain management strategies and reduce adverse outcomes. Selective COX-2 inhibitors, paracetamol, or tramadol may be safer alternatives for patients at risk of hypersensitivity. Further studies are required to validate these findings in larger cohorts.
Indexed as
Identifiers
40146260What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.